Is Vertex Pharmaceuticals Stock a Buy Now?
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) spiked recently in response to good news for an experimental new drug. The past year has been marked by one development setback after another, but recent developments make it look like it has a chance to come back stronger than ever.
Successful results from a clinical trial with a drug that isn't part of the company's successful cystic fibrosis franchise are generating a lot of stock market buzz for Vertex Pharmaceuticals again. Here's a look past the top-line results to see if now's a good time to buy the stock.
Image source: Getty Images.
Source Fool.com
